Poster: Nextflow-Powered Transformation: Migrating Genomics England’s Clinical Workflows

Topic:

Format:
  • PDF
Date:
  • Autors: Ardigen: Filip Chrzan, Olha Petryk, Dorota Pikul, Mateusz Rogalski, Przemysław Siekaniec, Błażej Szczerba Genomics England: Edwin Clark, Luke Paul Buttigieg, Ricardo Humberto Ramirez Gonzalez, Neil Goodgame, Mickey Kim, Tim Richardson
Download poster

Migrating Clinical Workflows to Nextflow: Lessons from Genomics England & Ardigen

About the poster

To enhance its genomic medicine offerings, Genomics England partnered with Ardigen to migrate its in-house clinical workflow management system, Bertha, to a more flexible solution based on Nextflow. Over the course of several months, we successfully completed this project, gaining valuable experience in the process. This poster outlines the key aspects of our migration effort for the benefit of the reader and future projects involving the transition of workflows to Nextflow.

This poster was originally presented during the BioIT 2025 Conference.

You might be also interested in:

Molecular structure representing AI-supported antibody design for blood-brain barrier research
How BBB-Penetrating Antibodies Cross the Blood-Brain Barrier
,
Life sciences conference takeaways 2026 - AACR, PEGS Boston, SLAS Europe, and Bio-IT World summary on AI in drug discovery
What 4 Life Sciences Conferences Revealed About AI in Drug Discovery
Life sciences professional using a tablet in front of digital data infrastructure screens
Scaling AI in Life Sciences: Why Data Infrastructure Determines Success
Large Language Model platform for patient-friendly content

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!